Your Molecule. Our Mission.™
With broad, deep-scale and expertise in small molecule development sciences, delivery technologies, and multi-modality manufacturing, Renejix Pharma Solutions is a preferred Contract Development and Manufacturing Organization (CDMO) partner for orphan drugs, blockbuster drugs, generics, and consumer health brand extensions.
Renejix is a premier partner in enabling pharmaceutical partners to optimize oral dosage small molecule product development, launch, and full life-cycle supply for patients around the world. Leverage our vertically integrated manufacturing sites, laboratories, distribution sites, supply chains, technologies, and our workforce.
Innovative Formulation Development for Poorly Soluble Drugs: Renejix is a leader in the field of formulation development for small molecules with poor solubility. Our innovative techniques and cutting-edge technology are dedicated to enhancing the solubility and bioavailability of these challenging compounds, ensuring that our partners have access to the most effective solutions available.
Expert Clinical Material Manufacture: Our state-of-the-art facilities are fully equipped to produce a diverse range of products. We pride ourselves on our meticulous attention to detail and our commitment to quality, ensuring that each batch of clinical material exceeds industry standards.
End-to-End CDMO Services: With two state of the art GMP facilities (totaling ~500,000 square foot) our comprehensive CDMO services are designed to be fully integrative, covering all aspects from formulation to commercial manufacturing and post-life cycle management. We work in close partnership with our clients to tailor our services to their unique project requirements, facilitating a smooth and efficient development process.
Client-Centric Business Development: Our approach to business development is rooted in a deep understanding of our clients’ needs. We are dedicated to being responsive, thorough, and collaborative, ensuring that we fully comprehend your project’s requirements before providing a customized proposal that aligns with your goals for quality, insight, timely delivery, and competitive pricing.
Markets We Serve
Renejix Pharma Solutions caters to companies seeking innovative technical solutions for the development of new forms of existing medicines. our advanced technical capabilities can be instrumental in realizing your product development aspirations: whether you need a lipid-based delivery mechanism, new amorphous dosage form, a reduced particle size, or alternative patient centric dosage forms, we have the technical expertise and the infrastructure to get it done. We develop products for controlled release, products, disintegrating, and many other unique dosage forms. We tailor development programs for your unique product, ensuring that your intellectual property is safeguarded, and your development timeline remains on course.
There are many small pharma companies that have made significant discoveries in drug molecules. They may have identified new compounds with promising activity against particular health targets. Both emerging and virtual pharma companies play a vital role in the pharmaceutical industry by driving innovation and bringing new drugs to market. They are agile and can move quickly from discovery to proof-of-concept, which is essential for the fast-paced nature of medical advancements. However, they often face challenges due to limited resources and expertise in drug formulation, which is crucial for advancing their discoveries to the clinical trial phase. If this is your company, Renejix can help. We provide pre-formulation data package development, API assessments, drug characterization formulation development, small-scale formulations for conducting toxicology studies and initial in-vivo animal studies, and assessment of likely formulation development options for first in man trials, phase I-III, and commercial manufacturing.
With a comprehensive understanding of solubility enhancement technologies, Renejix Pharma Solutions is at the vanguard of generic formulation development. We navigate the complexities of patent expirations with expertise, delivering high-quality generic formulations for a variety of delivery methods.